Alnylam thinks it has strong enough clinical data for its gene-silencing drug for rare disease acute
Read More
Triple-negative breast cancer patients lack three common markers—estrogen, progesterone and HER2—mak
Read More
Biogen’s top-selling Tecfidera (dimethyl fumarate) has proven to be an effective treatment for multi
Read More
Aurobindo pledged to resolve issues at a sterile manufacturing plant in India last year after an FDA
Read More
A change to European rules on drug manufacturing that could benefit makers of generics and biosimila
Read More
The FDA this week posted a Form 483 (PDF) for the Dr. Reddy’s solid dose plant in Pradesh that was i
Read More
North America segment net sales were down 18% to $4.10 billion, which the company said was partly dr
Read More